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Abstract
Background: Most filarial nematodes contain Wolbachia symbionts. The purpose of this study was to examine the
effects of doxycycline on gene expression in Wolbachia and adult female Brugia malayi.
Methods: Brugia malayi infected gerbils were treated with doxycycline for 6-weeks. This treatment largely cleared
Wolbachia and arrested worm reproduction. RNA recovered from treated and control female worms was labeled
by random priming and hybridized to the Version 2- filarial microarray to obtain expression profiles.
Results and discussion: Results showed significant changes in expression for 200 Wolbachia (29% of Wolbachia
genes with expression signals in untreated worms) and 546 B. malayi array elements after treatment. These
elements correspond to known genes and also to novel genes with unknown biological functions. Most
differentially expressed Wolbachia genes were down-regulated after treatment (98.5%). In contrast, doxycycline had
a mixed effect on B. malayi gene expression with many more genes being significantly up-regulated after
treatment (85% of differentially expressed genes). Genes and processes involved in reproduction (gender-regulated
genes, collagen, amino acid metabolism, ribosomal processes, and cytoskeleton) were down-regulated after
doxycycline while up-regulated genes and pathways suggest adaptations for survival in response to stress (energy
metabolism, electron transport, anti-oxidants, nutrient transport, bacterial signaling pathways, and immune evasion).
Conclusions: Doxycycline reduced Wolbachia and significantly decreased bacterial gene expression. Wolbachia
ribosomes are believed to be the primary biological target for doxycycline in filarial worms. B. malayi genes essential for
reproduction, growth and development were also down-regulated; these changes are consistent with doxycycline
effects on embryo development and reproduction. On the other hand, many B. malayi genes involved in energy
production, electron-transport, metabolism, anti-oxidants, and others with unknown functions had increased expression
signals after doxycycline treatment. These results suggest that female worms are able to compensate in part for the loss
of Wolbachia so that they can survive, albeit without reproductive capacity. This study of doxycycline induced changes
in gene expression has provided new clues regarding the symbiotic relationship between Wolbachia and B. malayi.
Keywords: Doxycycline, Brugia malayi, Wolbachia, Filariasis, Gene expression, Microarray
Background
Like many filarial nematodes, Brugia malayi contain
intracellular Wolbachia bacteria (wBm) [1-3]. These
obligatory endosymbionts are essential for larval growth
and development and for adult worm reproduction and
survival [4-7]. They multiply by binary fission and are
vertically transferred to successive generations of
worms. Metabolic interdependence of endosymbionts
and their hosts is common [8-10]. Two fundamental
questions remain in this mutualistic relationship: what
do wBm contribute to the nematodes and what do the
worms provide for the bacteria?
wBm have been considered to be important biological
targets for drug development against filarial nematodes
* Correspondence: rrao@dom.wustl.edu
1Infectious Diseases Division, Department of Internal Medicine, St. Louis,
Missouri, USA
Full list of author information is available at the end of the article
Rao et al. Journal of Biomedical Science 2012, 19:21
http://www.jbiomedsci.com/content/19/1/21
© 2012 Rao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
[11,12]. Many antibiotics have been tested in vitro and
in vivo against wBm and filarial worms. Of these, tetra-
cycline and related drugs have been shown to be effec-
tive in vitro, in animal models, and in humans against
filarial infections [6,13-18]. Tetracyclines also have pro-
phylactic activity, and they can cause a male-biased sex-
ratio [19-21]. Doxycycline (Doxy) reduces microfilaremia
and adult worm burdens by sterilizing adult worms and
eventually killing them (in filarial species containing
Wolbachia), either alone or in conjunction with diethyl-
carbamazine (DEC) or ivermectin [22-26]. In many of
these studies, antibacterial effects of the drugs precede
the effects on worms. In contrast, microfilariae and
adult worms of filarial species that lack Wolbachia such
as Acanthocheilonema viteae and Loa loa are not
affected by tetracyclines [27,28]. Therefore the effect of
tetracyclines in filarial worms with wBm is believed to
be related to their effect on the bacteria and not due to
direct effects on the worms. Some authors have sug-
gested that wBm may provide key molecules or meta-
bolic functions that are essential for survival and
reproduction in species that are wBm dependent [29,30].
Doxycycline primarily affects bacterial growth and survi-
val by inhibiting the binding of amino-acyl tRNA in
ribosomes which blocks protein synthesis [31,32]. At
higher concentrations, doxy has been shown to affect
mitochondrial function [33,34].
Despite their occurrence in several filarial nematodes
and their emergence as a therapeutic target, little is
known regarding biological interactions between wBm
and filarial worms [29,30]. A differential display PCR-
based approach has been used to look at changes in
gene expression in Litomosoides sigmodontis after tetra-
cycline treatment [35]. A number of genes showed
increased expression after doxy including a phosphate
permease gene (Ls-ppe-1) which may be essential for
embryo development. The genomes of wBm and Bm
provided more clues regarding potential mechanisms of
interdependence [29,36,37]. For instance, comparative
genome studies suggested that wBm contains pathways
for production of riboflavin, flavin adenine dinucleotide,
heme, and nucleotides that are lacking in B. malayi. In
addition, since the wBm genome lacks complete bio-
chemical pathways for de novo synthesis of biotin, coen-
zyme A, NAD, ubiquinone and folate, filarial worms
may provide these and other molecules that are required
for bacterial growth. wBm also lack synthetic pathways
for most amino acids [29], and they probably obtain
amino acids from their filarial hosts [36].
In this study we have examined the effects of 6-week
doxy treatment on wBm and Bm, and used V2 Bm
microarray to observe changes in expression profiles of
many genes; a subset of these genes may play a role in
survival and reproduction of female worms.
Methods
Ethics statement
All animals were handled in strict accordance with good
animal practice as defined by the Animal Welfare Act,
the Guide for the Care and use of Laboratory Animals
and guidelines of the Division of Comparative Medicine,
Washington University School of Medicine.
Infections and parasites
Mongolian gerbils (Meriones unguiculatus) (Charles River
Laboratories, Wilmington, MA) were inoculated subcuta-
neously (s.c.,) with 150 B. malayi L3 larvae as described
previously [38]. Adult worms at 180 days post-infection
were recovered from testis, spermatic cord lymphatics,
heart and lungs. Female worms were separated from
males, washed in RPMI-1640, and were snap frozen in dry
ice/ethanol and stored at -80 C. All worms recovered from
s.c., infections used in this study were of the same age
group but derived from different gerbils.
In vitro culture of female worms
Brugia malayi female worms from treated and untreated
gerbils were cultured in vitro to assess microfilaria (MF)
release, and the number of released MF were counted
on days 2, 4, and 6 of culture [6]. Briefly, 5 worms were
incubated per well in 6-well culture plates (Costar, Cam-
bridge, MA) in 5 ml of complete medium (RPMI-1640
supplemented with 25 mM HEPES buffer, 2 mM gluta-
mine and 10% fetal calf serum) at 37 C in a 95% air-5%
CO2 atmosphere.
Doxycycline treatment and worm recovery
Subcutaneously infected gerbils (n = 6) with circulating
microfilaria at approximately 140 days post infection were
treated by oral gavage with doxy (Sigma Chemical Com-
pany, St. Louis, MO) in distilled water at 100 mg/kg body
weight, daily for 6 weeks. Controls were untreated. At the
end of the treatment, animals were necropsied, and worms
were removed from animal tissues.
Microfilaria counts and embryograms
MF in 10 μl of tail-blood of treated and untreated ani-
mals were counted in duplicate after 1, 2, 4 and 6 weeks
of treatment [39]. Brugia malayi female worms recovered
after 6 weeks of doxy treatment and control worms were
studied to produce embryograms as previously described
[6]. Differences between embryograms of treated and
control worms were analysed by One-way ANOVA.
Electron microscopy
Female worms from treated and untreated gerbils were
fixed in 100 mM phosphate with 2% paraformaldehyde
and 2.5% glutaraldehyde and post-fixed in 1% osmium
tetroxide in phosphate buffer. Sections were stained,
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dehydrated in ethanol and embedded in Eponate 812
(Ted Pella, Inc., Redding, CA). Ultrathin sections (70-90
nm) were stained with uranyl acetate and lead citrate
and viewed with a JOEL 1200 transmission electron
microscope [6].
RNA isolation, cDNA probe synthesis, and microarray
analysis
Two groups of 15 female worms each from doxy treated
and untreated animals (biological replicates) were
crushed, and total RNA was extracted separately using
TRIzol (Invitrogen Corporation, Carlsbad, CA) and trea-
ted with DNase (Ambion, Austin, TX) as per the manu-
facturer’s instructions. RNA integrity and quantity were
measured with a Bioanalyzer-model 2100 (Agilent tech-
nologies Inc., Palo Alto, CA).
The Version-2 Filarial Microarray contains 18,104 oli-
gonucleotide elements (65mer) that uniquely represent
coding sequences for 15,412 B. malayi genes or predicted
genes, 804 Wolbachia genes, 1,016 Onchocerca volvulus
genes, and 872 Wuchereria bancrofti genes. A recent
publication provides extensive annotation for this array
[40]; see also http://www.nematode.net).
In a preliminary experiment, we synthesized cDNA
from RNA samples using oligo(dT) primers and Super-
script II Reverse Transcriptase (Gibco BRL, Gaithers-
burg, MD). Hybridizations, scanning and data analysis
were performed as previously described [40,41]. Oligo
(dT) priming has been the most widely used method for
conversion of mRNA into cDNA through reverse tran-
scription [42,43]. However, these experiments did not
provide optimal hybridization signals for bacterial tran-
scripts which lack polyA. Therefore, later experiments
employed a random priming method for probe synth-
esis. Briefly, cDNA was synthesized from 2 μg of RNA
using a Genisphere kit (Hatfield, PA) according to the
manufacturer’s instructions (http://www.genisphere.
com/pdf/array900mpx_protocol_v06-22-04.pdf). In order
to have technical replicates, cDNA probes were dye
labeled separately with Cy5 and Cy3 as per the manu-
facturer’s instructions (PerkinElmer Life and Analytical
Sciences, Waltham, MA).
Dye-labeled cDNA probes were hybridized to duplicate
65 mer oligos on the V2 filarial array. Two biological
replicates and two technical replicates provided 8 hybri-
dizations for each filarial oligomer on the array. cDNA
hybridizations were done overnight at 43 C with the
3DNA Array 900 detection system. The slides were
washed, and scanning and gridding were performed with
a ScanArray Express HT Scanner-v3.0 (Perkin Elmer,
Boston, MA). Photomultiplier tube (PMT) values were
set to 68 and 59 volts for Cy3 and Cy5, respectively. An
additional scan was done for each slide with the PMT set
for 56 and 48 volts. The scanned fluorescence intensity
values were Lowess normalized and analyzed by Gene-
spring v7.2 (Agilent) and Partek Genomics Suite software
(Partek, St. Louis, MO). An average of four arrays for
each condition were considered and wBm and Bm ele-
ments were scored as “present” if the signal was ≥ 250 or
if the signal to background ratio was ≥ 2. All microarray
experiments were performed in agreement with the
MIAME guidelines. The microarray data sets have been
deposited into GEO (accession ID; GSE34976).
Genes with fold differences in expression equal to or
greater than two fold and a confidence level of 99% (P <
0.01, Student’s t-test) in pair-wise comparison between
treated and control worms were considered to be differ-
entially expressed.
Gene expression analysis by quantitative reverse
transcriptase polymerase chain reaction (qRT-PCR)
Known wBm gene sequences for 16s rRNA (wBm9003),
cell cycle gene-ftsZ (wBm0602), surface protein-wsp
(AJ252061), seven heme genes (wBm0133, wBm 0373,
wBm0777, wBm0728, wBm 0001, wBm0709 and wBm
0719), and B. malayi sequences for sheath protein-shp1
(U43568), embryonic fatty acid binding protein-FABP1
(AF178439), and actin (XM_001895760), were used to
amplify the corresponding transcripts in treated and con-
trol worm RNA by qRT-PCR. These experiments were
performed twice with two batches of worms. In addition,
a subset of differentially expressed wBm and Bm genes
from the microarray analysis was selected for assay con-
firmation studies by qRT-PCR. The expression profiles
for bm.03044, BMX1802, BMX9848, BMX8408, BMX
9336, BMX11510, BMX4544, bm.00532, bm.01661,
BMX2449 genes affected after antibiotic treatment (both
in our array study and in previous reports) were also ana-
lyzed by RT-PCR using 6 wks treated vs. untreated worm
cDNA. Primer pairs were designed from sequences
obtained from the wBm genome http://tools.neb.com/
wolbachia/) or from GenBank with Primer Express 3.0
software (Applied Biosystems, Foster city, CA). Sequence
specific primer pairs were purchased from Integrated
DNA Technologies, Coralville, IA. Briefly, cDNA was
synthesized using 1 μg of total RNA, random primers,
and SuperScript II reverse transcriptase (Invitrogen,
Carlsbad, CA). qRT-PCR reactions were performed in
duplicate in 96-well optical plates in a 25 μl reaction
volume containing 1 ng of cDNA with individually opti-
mized primer concentrations and SYBR green master
mix (Applied Biosystems). To ensure that there was no
genomic DNA contamination in cDNA and no primer
dimer artifacts, reactions containing templates generated
without reverse transcriptase enzyme were included as
controls. Water was also tested in each reaction as a “no
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template” control (NTC). Reactions were conducted with
an initial step of 2 min at 50 C and 10 min at 95 C, fol-
lowed by 40 cycles of 15 s at 95 C and 1 min at 60 C. A
melting curve analysis was performed at the end of each
cycle to assess the amplification specificity. Cycle thresh-
old (Ct) values were obtained for the target and internal
control gene. Brugia malayi histone gene (Pub_locus
Bm1_49345) Ct values were used as an internal control
to normalize transcript levels present in different sam-
ples. Real-time PCR efficiency (E = 10 - (1/slope)-1) was
monitored by generating standard curves for Bm histone
using log template concentration of cDNA from treated
and untreated worms and found to be close to 100%. The
relative quantitation method (2 -ΔΔCt) was used to com-
pare expression levels of wBM and Bm genes in different
samples [44] (http://www3.appliedbiosystems.com/cms/
groups/mcb_support/documents/generaldocuments/
cms_040980.pdf).
For correlation analysis, qRT-PCR results (2-ΔΔ Ct) of
selected wBm and Bm genes and their corresponding
microarray results (normalized ratios) were Log10 trans-
formed, and the results were analyzed by the nonpara-
metric Spearman rank correlation test using GraphPad
Prism v.4 software (GraphPad Software Inc, San Diego,
CA). qRT-PCR results for individual genes were ana-
lysed by one-way ANOVA to assess the significance of
differences between treated and control worms.
Functional classification of differentially expressed gene
transcripts
Functional analysis was carried out for differentially
expressed wBm and Bm genes to identify overrepre-
sented pathways using the Kyoto Encyclopedia of Genes
and Genomes (KEGG v.43) [45]. For each query, the top
match (with P < 1.0e-10) and all the matches within
30% of the top Blast score were accepted for KEGG
Ontology (KO) and pathway associations. Default para-
meters for InterPro Scan v13.1 were used to map
against InterPro database [46]. These mappings were
used to classify the gene transcripts as biological, mole-
cular, and cellular components. Gene Ontology map-
pings for wBm genes were selected from UniProtKB
database (http://www.uniprot.org/uniprot/) and from
InterProScan v13.1. Statistically enriched pathways and
gene ontology (GO) categories were obtained using
hypergeometric analysis with P < 0.05 considered signifi-
cant [47]. For non-redundant (NR) nucleotide hits, dif-
ferentially expressed genes were BLAST searched
(e-value cutoff of 1.0e-10) against a NR database with
no Caenorhabditis sequences. In addition, we used
Wormpep v.180 with an e-value cutoff of 1.0e-05 for
detecting Brugia malayi homologs of C. elegans genes
having RNAi phenotypes.
Results
Effect of doxycycline on Brugia malayi worms and
Wolbachia
Our aim was to study 6-week treatment effects of doxy
on adult female worms and their wBm. Doxycycline did
not reduce circulating MF counts in gerbils (Table 1).
Although there was some reduction (15%) in adult worm
recovery in the treated group, this difference was not sta-
tistically significant. Interestingly, female worms recov-
ered from treated gerbils did not release MF in vitro. In
contrast, MF counts on days 2 and 4 of culture from
untreated worms were 1.7 × 103 ± 0.5 × 103/ml and 2.1 ×
103 ± 0.9 × 103/ml, respectively. Embryograms of treated
worms were abnormal and different from those of con-
trol worms (see additional file 1). Late developmental
stages (stretched MF and pretzels) were markedly
reduced in treated worms relative to untreated worms.
Ultrastructural studies clearly showed wBm bacteria in
the hypodermis of untreated worms but not in treated
worms (Figure 1A, B). Degenerate worm embryos were
observed in treated worms (Figure 1D) while intact
embryos were present in controls (Figure 1C).
Effects of doxycycline treatment on Wolbachia gene
expression
The V2 Filarial array contains 804 wBm genes, and
hybridization signals were detected for 679 (84.5%) in
control female worm cDNA (see additional file 2).
Expression signals were detected for 538 (67%) of wBm
genes in doxy treated worm RNA (18% fewer than in
untreated worms).
Of 679 wBm genes with detectable expression signals
in control worms, the top twenty with the highest expres-
sion signals (median values 3.08E+03 to 1.02E+04)
included genes involved in protein synthesis (6), stress
response (4), antioxidant (1), energy and electron transfer
(1), copper acquisition and aerobic respiration (1) lipid
metabolism (2), DNA binding or repair (2), host interac-
tion and adaptation (3) and hypothetical (4) (see addi-
tional file 3). Expression signals for 140 wBm elements
were present in control worms and absent in treated
worms. The top 10 genes that showed highest expression
signals in control worms but ‘absent’ in treated worms
include molecular chaperonins, transcription and transla-
tion factors, membrane and ribosomal proteins and anti-
oxidants (see additional file 4). In contrast, signals for 98
wBm elements were present in treated worms but absent
in control worms (see additional file 4). The top 10 genes
with highest expression signals here include transport or
lipoprotein release (wBm 0483), secretion (wBm 0796),
proteolysis (wBm 0770), carbohydrate and aminoacid
metabolism (wBm 0666), cell wall biogenesis and pepti-
doglycan biosynthesis (wBm 0508), nucleic acid repair
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(wBm 0746), and integral membrane protein TerC (wBm
0442) which may be involved in resistance to antibiotics.
The scatter plots displaying the mean normalized
fluorescence intensity signals for all elements on the
array (panel A) and for wBm elements alone (panel B)
met the criteria for gene expression in treated vs. con-
trol samples (see additional file 5).
Of 538 wBm genes with expression signals in treated
worms, two hundred (37%) genes having signals in both
treated and control worms showed differential expres-
sion (≥ 2, P ≤ 0.01), and all but 3 of these were down-
regulated (see additional file 6). wBm0474, which may
be essential for electron transfer and energy metabolism,
showed increased expression. Among the down-regu-
lated genes 38 (19%) were ribosomal transcripts. The
top 18 genes with known functions that showed signifi-
cantly lower expression include transcripts involved in
translation, DNA replication, recombination and repair,
surface protein, Type IV secretory system, or nucleotide
and nucleoside metabolic processes; these functions are
associated with the cell nucleus, ribosome, cytoplasm or
cell membrane (Table 2).
Table 1 In vivo effects of doxycycline on Brugia malayi microfilaria (MF) and adult worms
Stage % of pretreatment MF counts (mean ± SD) Mean (± SD) number of worms
(% reduction in worms)
Days after treatment
7 14 28 42 42
Treated MF 121 ± 74 119 ± 30 200 ± 95 192 ± 101 -
Control MF 167 ± 135 90 ± 18 143 ± 108 112 ± 92 -
Treated Adult worm - - - - 29.3 ± 18 (15)
Control Adult worm - - - - 34.5 ± 10
Gerbils (n = 6) were treated with doxycycline (100 mg/kg/bw/per os). Controls were untreated. During 6 weeks of treatment, on day 7, 14, 28, and 42 no
significant reduction in MF counts was observed. Reduction in worm recovery at the end of the treatment between control and treated gerbils was not
significant.
Figure 1 Transmission electron micrographs of Brugia malayi female worms. Panel A and C are sections of untreated female worm. Panel
A shows numerous Wolbachia (arrows) in the hypodermis. Panel C shows, intact embryos in the uterus. Panel B and D are sections from
doxycycline treated worms. The hypodermis is free of Wolbachia (Panel B) and only degenerate embryos were present in the uterus of treated
worms (Panel D). U, uterus; C, cuticle; UW, uterine wall; MF, microfilaria; mtr, mitochondria. Scale bar = 1 μm.
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KEGG data search revealed that out of 804 wBm genes
on the microarray, 499 were mapped to many pathways
ranked by gene abundance, and 487 had KEGG ontology
(KO) assignments (see additional file 7). Many mapped
genes were associated with pathways in metabolism
(221), genetic information and processing (215), envir-
onmental information and processing (46) and cellular
processes (13). Out of 200 wBm genes that were differ-
entially expressed after doxy treatment, 141 (70%) genes
were mapped to pathways, and significantly enriched
pathways (P ≤ 0.05) associated with down-regulated
genes include bacterial ribosome, translation factors,
and the pentose phosphate pathway in carbohydrate
metabolism (Table 2, see additional file 7). In contrast,
two wBm genes (wBm 0474, wBm 0365) with increased
expression after treatment mapped to pathways involved
in energy metabolism, nucleic acid replication/protein
repair, respectively (see additional file 7). The third up-
regulated gene (wBm0149) is a hypothetical gene and its
function is unknown. GO term assignments were concor-
dant with KEGG results, and many biological processes
and molecular functions in wBm were down-regulated
after doxy treatment (see additional file 6). InterPro scans
showed a total of 366 protein domains mapped in wBm
gene transcripts, and only two of these domains related
to nucleic acid binding and to an unknown function were
significantly (P < 0.05) enriched in down-regulated wBm
genes (see additional file 8). The protein domains
mapped to the up-regulated wBm 0474, wBm 0365 genes
are related to the respiratory chain proteins NADH-qui-
none oxidoreductase and dehydrogenease subunits and
DNA repair proteins.
Effect of doxycycline treatment on Brugia malayi (Bm)
gene expression
Of 15,412 Bm elements on the array, 13,399 had hybridi-
zation signals in control adult female worms. Signals
were detected for 14,340 elements in doxy treated worm
cDNA (see additional file 2). 53 Bm elements were pre-
sent in control worms and absent in treated worms. In
contrast, 994 Bm elements were present in treated but
absent in control worms. Of 53 elements uniquely pre-
sent in control worms, elements for 15 genes have no
annotation in the database and 9 were hypothetical (see
Table 2 Description of top 20 differentially expressed Wolbachia genes found in doxycycline treated Brugia malayi
female worms
Functional class Systematic Annotation# Fold change P-value Signal Description
Protein synthesis
BMX14197 wBm0431 0.12 1.84E-05 Down DNA-directed RNA polymerase sigma 32 subunit, RpoH
BMX14096 wBm0328 0.11 4.19E-05 Down Ribosomal protein S14
BMX14288 wBm0521 0.23 7.90E-05 Down Ribosomal protein S21
BMX14418 wBm0650 0.12 9.18E-05 Down Ribosomal protein L1
BMX14100 wBm0332 0.10 9.84E-05 Down Ribosomal protein S17
BMX14101 wBm0334 0.19 1.01E-04 Down Ribosomal protein L16
BMX14113 wBm0346 0.16 1.14E-04 Down Ribosomal protein S12
BMX14026 wBm0258 0.21 5.92E-05 Down Ribonuclease D
DNA replication, DNA recombination, DNA repair or SOS response
BMX14200 wBm0434 0.06 1.56E-05 Down DNA polymerase III, gamma/tau subunit
BMX14193 wBm0427 0.25 5.30E-05 Down RecA recombinase
BMX14131 wBm0365 3.06 1.19E-03 Up Predicted EndoIII-related endonuclease
BMX14476 wBm0708 0.13 1.22E-04 Down Superfamily II DNA/RNA helicase
Energy production and conversion
BMX14457 wBm0689 0.09 8.65E-05 Down F0F1-type ATP synthase, beta subunit
BMX14240 wBm0474 3.16 1.49E-03 Up NADH:ubiquinone oxidoreductase
Metabolism & Transport
BMX14214 wBm0448 0.14 1.40E-04 Down Succinate dehydrogenase flavoprotein subunit, SdhA
BMX13916 wBm0146 0.23 1.38E-04 Down Kef-type K+ transport system, membrane component
BMX13899 wBm0129 0.27 1.09E-04 Down Ornithine/acetylornithine aminotransferase
BMX13796 wBm0024 0.15 1.06E-05 Down HesB/YadR/YfhF family protein
Secretion
BMX14563 wBm0795 0.18 1.27E-04 Down Type IV secretory pathway, VirB6 components
Immunogenic membrane components
BMX14198 wBm0432 0.06 1.21E-04 Down Outer surface protein-wsp
Expression of listed Wolbachia genes was down-regulated and those shown in italics were up-regulated after doxycycline treatment in vivo.
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additional file 9). Known genes included cytoskeletal
genes (actin, myosin), the antioxidant glutathione S-
transferase (GST), and ribosomal proteins (S1 and L11).
KEGG analysis showed pathways associated with metabo-
lism (biosynthesis of secondary metabolites, xenobiotic
metabolism and degradation, and glycan biosynthesis),
cellular processes (cell motility and communication, and
immune system), and human diseases were enriched sig-
nificantly (P ≤ 0.05) in control worms (see additional file
10). Of 994 genes with expression signals in treated
worms but not in control worms, many were classified as
hypothetical (288), ribosomal (8) and novel genes (~480)
with no annotation. Known genes in this group included
cuticular components, proteases (astacin and ADAMTS-
like metalloproteases, cathepsin-L (cpl-1), vespid allergen
antigen homolog (Val), immunogens and immunomodu-
lators (Alt-1) (see additional file 9). KEGG pathways sig-
nificantly (P ≤ 0.05) enriched in treated worms included
metabolism of carbohydrates and secondary metabolites,
energy metabolism (oxidative phosphorylation), and
nucleotide metabolism. In addition, pathways involved in
genetic information and processing (translation, folding),
signaling pathways and various other cellular processes
(cell motility, cell growth and communication) were
enriched in treated worms (see additional file 10). Many
GO terms assigned for genes present in control worms
and treated worms or vice versa corresponded to path-
ways analysed by KEGG, and only those significantly (P <
0.05) enriched are listed in additional file 10.
546 Bm genes present in both control and doxy treated
worms were differentially expressed after doxy treatment
(see additional file 2). Of these, 462 were up-regulated
including those that encode genes associated with energy
metabolism, electron transport, antioxidants, antigenicity,
immuno-modulation/evasion, and many novel or pre-
dicted genes with unknown biological functions (Table 3;
see additional file 11). Interestingly, we observed that
many mitochondrial transcripts with oxidoreductase
activity (14981.m02381, 14243.m00195, 14972.m07606,
13478.m00071, 14773.m00936, BMC11992) were signifi-
cantly up-regulated. In addition, mitochondrial tran-
scripts of complex II (cytochrome c-oxidase) and
complex III (ubiquinol-cytochrome c-oxidase) subunit
which are associated with oxidative phosphorylation in
energy metabolism and electron transfer were signifi-
cantly up-regulated, whereas NADH dehydrogenase sub-
unit-5 was down-regulated. The 84 (16%) Bm genes that
were down-regulated after treatment included many
known genes that encode cuticular components (col-
lagen, caveolin and cadherin), embryonic fatty acid bind-
ing protein, and novel genes with unknown functions
(see additional file 11). Of 14,340 elements with hybridi-
zation signals in treated worms (see additional file 2), sig-
nals for 34 heat shock associated transcripts were
detected including small heat shock proteins, Hsp-90,
and Hsp-70 in treated and untreated worms (data not
shown). However, these were not differentially expressed.
KEGG and InterPro analysis of differentially expressed B.
malayi genes
KEGG-based analysis mapped 60 Bm genes that were
differentially expressed after doxy treatment to different
pathways. Several of these were grouped to environmen-
tal information and processing, genetic information and
processing, metabolism and transport (Figure. 2, see
additional file 11, 12). Transport and signaling pathways
significantly enriched (P ≤ 0.05) were mapped to up-
regulated genes. Significant pathways mapped to down-
regulated Bm genes included amino acid metabolism,
cellular processes and ribosomal functions (see addi-
tional file 12, Figure 2). InterPro analysis showed that a
large number of up-regulated genes contained zinc fin-
ger domains and retroelements (see additional file 13).
Other protein domains associated with integration of ret-
roelement cDNA into host genome (integrase, polynu-
cleotidyl transferase) were also enriched in up-regulated
genes. Other domains in this group were associated with
immune evasion (ALT), proteases (aspartic acid
proteases) and energy metabolism (glyceraldehyde
3-phosphate dehydrogenase). Enriched protein domains
mapped to the down-regulated genes included ribosome,
cytoskeleton and bacterial protein transport. The com-
plete list of significant protein domains is shown in addi-
tional file 11, 13. DNA integration (GO: 0015074),
proton (GO:0015992), electron (GO:000618) and ion
transport (GO:0006813), signaling cascades (GO:000
7242, GO:0007186), glycolysis (GO:0006096) were some
of the highly represented biological function ontologies
linked to up-regulated Bm transcripts. Phosphate trans-
port (GO:0006817), regulation of translation and tran-
scription (GO:0006350, GO:0045449, GO:0006414) and
protein biosynthesis (GO:0006412) and transport
(GO:0015031) were highly represented biological ontolo-
gies to down-regulated Bm transcripts. The other major
molecular functions and cellular components enriched in
GO are listed in additional file 11.
Comparison of observed changes in Brugia malayi and
Litomosoides sigmodontis gene expression after
doxycycline/tetracycline treatment
We compared our results with those recently reported
after i.p. tetracycline treatment of Bm and in L. sigmo-
dontis [48,49]. We have observed expression of more
genes to be regulated after doxy treatment in Bm com-
pared to the two previous reports (319 and 323 vs 546
respectively). However, only few genes (1% or 5/546)
regulated at 6 wks doxy treatment agreed with differen-
tially expressed genes found in Bm or L. sigmodontis at
Rao et al. Journal of Biomedical Science 2012, 19:21
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Table 3 Major known differentially expressed* Brugia malayi genes after doxycycline treatment
Functional class Sequence OligoID Fold change P value Description Pub_Locus
Up-regulated
Electron transfer
BMC05513 bm.01224 5.12 1.04E-03 Cytochrome C oxidase Bm1_53760
14963.m01788 BMX5456 2.66 3.13E-03 Ubiquinol-cytochrome-c oxidase activity Bm1_34585
BMC01497 bm.00393 3.55 6.56E-03 ATP synthase F0 subunit 6
Antioxidants
14981.m02381 BMX7492 2.85 1.72E-03 Thioredoxin Bm1_46710
Proteases
BMW00062.466 BMX11239 3.12 1.42E-03 Cathepsin L-like cysteine proteinase Bm1_00065
13332.m00193 BMX1173 2.65 4.18E-03 Metalloprotease Bm1_07750
13632.m00184 BMX1614 2.01 7.91E-03 Trypsin family protein Bm1_10665
Metabolism and transport
14773.m00936 BMX4045 2.67 5.91E-03 Pyruvate dehydrogenase Bm1_25865
13478.m00071 BMX1447 2.00 5.55E-03 Malate/L-lactate dehydrogenase Bm1_09530
14981.m02410 BMX7517 3.61 3.27E-04 Biopterin-dependent aromatic amino acid
hydroxylase
Bm1_46865
14787.m00179 BMX4095 13.7 7.23E-06 Cysteine-rich, acidic integral membrane protein precursor, putative Bm1_15145
Immunogens
14222.m00064 BMX2433 10.3 2.76E-05 PPE family protein, putative Bm1_15875
BMC05381 bm.01203 2.13 4.10E-03 BmSERPIN Bm1_03995
12920.m00009 BMX601 2.49 6.84E-03 Excretory/secretory protein Juv-p120 Bm1_04050
BMC00351 bm.03044 2.27 2.65E-03 Vespid venom allergen
antigen-like protein 1
Bm1_14040
14399.m00013 BMX2941 2.51 7.90E-04 ALT protein Bm1_14360
13893.m00088 BMX1920 4.25 3.08E-03 IgG and IgE immunoreactive antigen Bm1_12575
BMC00480 bm.00167 4.40 2.76E-03 mmc1 #N/A
13673.m00036 BMX1683 3.03 1.05E-03 Mucin Bm1_11110
Down-regulated
Reproduction, development & transport
BMC00903 bm.00277 0.47 2.78E-03 Embryonic fatty acid-binding protein
Bm-FAB-1
Bm1_33050
12495.m00012 BMX108 0.26 8.99E-03 Collagen, putative Bm1_00775
15377.m00007 BMX9051 0.21 1.75E-03 Alpha-1 collagen type IX, putative Bm1_56350
AA109462 BMX9336 0.40 5.12E-03 Peptidyl-prolyl cis-trans isomerase Bm1_56870
BMC03244 bm.00803 0.45 4.98E-03 Prolyl 4-hydroxylase Bm1_45455
BMC02383 bm.00595 0.44 6.93E-04 Caveolin-1 Bm1_36280
14700.m00144 BMX3736 0.42 4.38E-03 Cadherin Bm1_24010
Electron transfer
BMC02188 bm.00554 0.30 2.20E-03 NADH dehydrogenase subunit 5 Bm1_56750
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earlier time points. The expression of vespid venom
allergen homolog (BMC00351) while it was down- regu-
lated in Bm at 2 wks of treatment, found up-regulated
at 5 and 6 wks in L. sigmodontis and Bm. Genes encod-
ing hypothetical (BMX1802, BMX9848), trafficking pro-
tein (BMX 8408) and peptidyl-prolyl cis-trans isomerase
(PPI-FKBP type, BMX9336) transcripts were up-regu-
lated at 2 wks but down-regulated at 6 wks of treatment
in Bm. In addition, the Bm homologs of seven-trans-
membrane-helix (7TM) receptor (BMX11510), zinc fin-
ger family protein (BMX4544) and 2 hypothetical
proteins (bm.00532, bm.01661) found in L. sigmodontis
were in agreement with regulated (up) genes at 6 wks.
However, expression of nucleotide-binding protein
(BMX2449) involved in signaling pathway was down in
L. sigmodontis at 5 wks but up at 6 wks in Bm. Our
microarray results for these genes were further con-
firmed by RT-PCR (data not shown).
Homologs of Caenorhabditis elegans genes with known
RNAi phenotypes in doxycycline treated B. malayi
A total of 321 genes of the 994 Bm elements present in
treated female worms and not in control worms have
homologues in C. elegans with RNAi phenotype informa-
tion. While 228 genes were wild type phenotypes, 93 had
abnormal phenotypes. Most of these are involved in
reproduction and development including 50 embryonic
lethal (Emb), 26 growth (Gro), 35 sterility (Ste) and ster-
ile progeny (Stp) phenotypes (see additional file 9).
272 of 546 (50%) Bm transcripts that were present in
both control and treated worms but differentially
expressed had homologues in C. elegans (see additional
file 11). More of the genes that were up-regulated after
doxy (231/272) had homologues than genes that were
down-regulated (41/272). RNAi phenotype information
was available for C. elegans homologues for 264 of 546
(48%) Bm genes. Of these, 207 homologues were wild
type, while 57 (36 up-regulated and 21 down-regulated
genes) had severe phenotypes in C. elegans including
sterility, larval arrest, embryonic lethality, egg laying
defect, sick, slow growth, etc. In addition, 19 down-regu-
lated Bm genes with observed phenotypes have been
reported to be female-regulated (Li et al, personal com-
munication). These included four collagen genes (15377.
m00007, 14845.m00009, 14296.m00065, 14296.m00063),
one histone (13785.m00207), and one hypothetical gene
Figure 2 Distribution of KEGG pathways mapped to up-regulated and down-regulated Brugia malayi genes after doxycycline
treatment. Many genes involved in transport, signaling, tanslation, metabolism and cell communication pathways were affected. Significant
canonical pathways (P ≤ 0.05) and number of genes mapped in each pathway and their percentages are shown in additional file 12 for
regulated genes.
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(BMC01609). Many other down-regulated Bm genes are
homologues of sterile phenotypes in C. elegans especially
Emb, Lva, Lvl, Ste phenotypes.
Gene expression analysis by qRT-PCR
qRT-PCR studies were performed for 37 genes with signifi-
cantly different expression signals between treated and
control worms by microarray. These included 25 Bm genes
and 12 wBm genes. qRT-PCR results were consistent with
array results for 25 of 37 genes (68%), and quantitative
results obtained with these two methods were significantly
correlated (R = 0.4352; P = 0.007) (Figure 3). In some cases
without agreement, differences by qRT-PCR were in the
same direction as those observed by microarray, but the
qRT-PCR differences were not statistically significant.
qRT-PCR studies showed significant down-regulation of
wBm 16S, ftsZ and wsp expression in doxy treated female
worms relative to controls. Down- regulation was more
impressive for 16S and wsp genes compared to ftsZ (see
additional file 14). Embryo associated genes Bm-shp1 and
FABP transcripts were significantly (P < 0.05) down-regu-
lated in treated worms, while treatment did not signifi-
cantly affect actin expression. Interestingly, expression of
all 7 wBm genes in the heme synthesis pathway was signif-
icantly down- regulated in treated worms by qRT-PCR
(see additional file 14). Again, these results were generally
consistent with those obtained by microarray. Two genes
(wBm 0709 and wBm 0719) had no expression signal by
microarray in treated worms. Expression signals for the
other 5 genes were decreased in treated worms, although
only one of these (wBm 0133, 5-aminolevulinate synthase,
EC 2.3.1.37) met the criterion of a 2-fold reduction with P
< 0.01 (see additional file 3).
Discussion
Prior studies have shown that doxy affects wBm from filar-
ial worms with disruption of parasite development and
reproduction. Ultrastructural changes and changes in cell-
surface (wsp) and cell- cycle (fts-z) DNA markers relative
to controls indicate that doxy treatment reduces wBm bac-
teria in female worms. The purpose of this study was to
examine the effects of doxy treatment on gene expression
in adult worms and in wBm. As expected, our results con-
firmed previous reports regarding the effects of doxy treat-
ment on wBm, embryogenesis and MF production in
adult filarial worms [6,13,15,16,23,24,50,51]. Although
there are reports that doxy kills adult worms in some in
vivo systems, our results showed that Brugia malayi
worms survived 6 wks of doxy treatment in gerbils. Surviv-
ing worms were not normal, and a longer post-treatment
observation period might have shown that doxy shortened
the lifespan of adult female worms.
We then turned our attention to gene expression. We
first tested the efficiency of cDNA probes synthesized by
oligo(dT) priming for hybridization and signal detection.
This method detected expression signals in adult female
worms for 12,791 of 18,101 elements on the array (data
not shown). However, this method was not reliable for
detecting wBm genes, which lack poly-A tails. Oligo(dT)
primers also have a tendency to produce truncated
cDNAs through internal poly(A) priming, and this can
reduce the quality of synthesized cDNA [42,52]. Random
priming of total RNA for synthesis of hybridization probes
[53,54] worked well for transcripts of both wBm and Bm.
Untreated control female worms had transcription signals
for 84% of wBm genes, with most genes showing ≥ 3.08 ×
103 fluorescence units. Presumably some of these wBm
genes are critical for bacterial survival and for mainte-
nance of the mutualistic relationship association with their
filarial host. Many wBm gene expression signals were
absent or significantly reduced after doxy treatment [55].
This finding was expected as doxy treatment kills and
clears wBm from filarial worms. It is unclear why three
wBm genes had increased expression signals after doxy
treatment; wBm0474, associated with energy metabolism
and metabolism of cofactor molecules and wBm0365
which is involved in DNA replication and repair were up-
regulated. Similarly, in other studies of gene expression in
tetracycline treated worms, expression of many wBm
genes was differentially expressed with 13 genes in B.
malayi (at day 14) and 3 genes in L. sigmodontis (at day
36) up-regulated [48,49]. These results suggest that some
wBm and wBm DNA persists after at least 6 wks of doxy
treatment.
Figure 3 Correlation between expression values for Wolbachia
and Brugia malayi genes obtained by microarray (y-axis) and
qRT-PCR (x-axis). Normalized fold change values of microarray
experiment and 2-ΔΔ Ct values of qRT-PCR obtained for the same
genes were Log transformed and analysed by the nonparametric
Spearman rank correlation test (R = 0.4352; P = 0.007).
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We found over representation of wBm genes in path-
ways such as carbohydrate metabolism, energy metabo-
lism, aminoacid metabolism and nucleotide metabolism
that were affected by doxycycline treatment. Complete
pathways for de novo biosynthesis of nucleotide/nucleo-
side biosynthetic genes are present in the wBm genome,
and this has been postulated as a basis for Wolbachia
dependence in filarial worms [29]. Similarly, computa-
tional predictions suggested that wBm genes (~552
genes) may be essential for certain pathways [56]. We
observed that many genes predicted to have these func-
tions were down regulated after doxy treatment.
Two recent reports described effects of tetracycline
treatment on gene expression in Bm and L. sigmodontis
[48,49]. Our study confirmed some of these observations
(down-regulation of transcripts essential for transcription,
translation), but there were also important differences
(e.g., reduced expression of genes involved in reproduction
and development, see Table 3). For example, Ghedin et al.,
[48] reported overexpression of Bm transcripts involved in
amino acid synthesis and protein translation and down-
regulation of cuticle synthesis transcripts very soon after
tetracycline treatment (14 days). Similarly, while many
transcripts involved in transcription and translation, and
in metabolic and signaling pathways were down regulated,
motility, heme-binding protein, and mitochondrial tran-
scripts encoding energy metabolism were up-regulated
after treatment in Litomosoides [49], and a similar profile
for energy genes was reported for Bm [48].
In addition to the timing of gene expression changes in
filarial worms, the experimental design and data analysis
may explain differences in microarray results in the pre-
sent study from those reported in prior studies. For exam-
ple, the infection method (i.p., vs. s.c.,), medication used,
mode and duration of drug treatment, and methods for
probe synthesis and gene expression analysis in the pre-
sent study differed in many ways from those used in the
other reports. It is difficult to quantify drug dosage when
medications are provided when it is in drinking water, and
drugs can have different effects on worms in different
locations in the host. In addition, we have used a more
stringent criterion for calling differential expression by
using > 2 fold change with P < 0.01 value as a parameter.
We think this increased stringency is important to reduce
false calls for differential gene expression in large
microarrays.
Our study found striking increases after treatment in
expression of genes encoding proteins involved in immu-
noregulation, electron transfer and energy metabolism.
Many immune evasion gene transcripts were highly
expressed in worms (Table 3) [57]. In addition, we found
that Brugia mmc1 transcript (reported to be specific for
MF stage, see [58], an immunogen was up-regulated in
doxy treated female worms by microarray, and this result
was confirmed by qRT-PCR. Activation of immune
evasion functions may be needed for treated worms to
survive, because the loss of wBm might otherwise render
the worms more susceptible to host immune responses.
Up-regulation of mitochondrial genes involved in elec-
tron transfer and respiratory chain after treatment sug-
gests that doxy treatment may directly affect targets
other than wBm such as worm mitochondria [33]. This
increased expression of mitochondrial transcripts after
doxy treatment may partially protect filarial worms from
the loss of wBm so that they can survive. Interestingly,
tetracycline has no direct effect on Wolbachia-free
A. viteae worms or their mitochondrial respiratory chain
transcripts [49]. Additional research will be needed to
test the hypothesis that mitochondria and wBm may have
overlapping or complimentary roles in Bm worms.
Heme is an essential factor for development, survival
and fertility of many nematodes. The wBm genome con-
tains all but one of the genes required for heme synthesis
[29,30]. In contrast, only 1 gene in the heme biosynthetic
pathway is present in the B. malayi genome (ferrochela-
tase, EC 4.99.1.1, Bm1_14320). This led to the hypothesis
that filarial worms may depend on wBm for heme synth-
esis. Recent studies that showed that inhibitors of heme
synthesis by Wolbachia reduced worm viability support
this hypothesis [59]. Our qRT-PCR studies found
decreased expression of all wBm genes involved in heme
synthesis in doxy-treated treated female worms. Microar-
ray results were similar, but less impressive. Recently,
Strübing et al., [49] postulated that up-regulation of
mitochondrial genes was essential for worms to maintain
mitochondrial heme-dependent respiratory chain protein
complexes for energy and homeostasis without Wolba-
chia. Our results support this hypothesis.
Many previous studies have reported changes in filarial
worm embryogenesis and development after doxy treat-
ment. Wolbachia is known to affect host oogenesis in
insects, possibly by affecting expression of genes involved
in this process [60,61]. We observed that after the loss of
wBm, many known Bm gene transcripts essential for cytos-
keleton and extracellular matrix synthesis (prolyl 4-hydro-
xylase, collagen/cuticulin, laminin, and caveolin) and
transcripts believed to be involved in embryogenesis and
reproduction (embryonic fatty acid binding protein and
cathepsin-L) were down-regulated [62-66]. Although,
phosphate permease family gene (Ls-ppe-1) thought to be
involved in nucleotide metabolism was up-regulated after
tetracycline treatment, orthologues in Bm were not up-
regulated at 6 wks of treatment. However, other phosphate
transport genes in Bm were down-regulated after doxy
treatment. This suggests that doxy may significantly affect
phosphate transport to Bm and that dysregulation of phos-
phate and nucleotide metabolism could impair Bm embryo
development. Down-regulation of development-associated
Rao et al. Journal of Biomedical Science 2012, 19:21
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transcripts like FABP1 and shp1 after doxy by qRT-PCR
further supports the array results. Similarly, Ghedin et al.
[48] showed down-regulation of few collagen genes after
tetracycline treatment in Bm. Conversely many other col-
lagen collagen genes up-regulated in treated Litomosoides.
While other studies reported that expression of troponins
and several collagens was up-regulated in treated Litomo-
soides and Bm worms [49,67], our results did not confirm
these findings.
Zinc-finger domain genes have diverse roles in tran-
scriptional modulation, translational control, protein
degradation pathways, and growth regulation; and they are
believed to have diverse, important roles in filarial biology
[36,68]. We found that doxy treatment increased expres-
sion of these genes in Bm suggesting that protein-nucleic
acid and protein-protein interactions may be increased in
treated worms after the depletion of wBm. Based on NR
best hits in the protein sequences, transcripts encoding at
least 10 Bm genes that were differentially expressed after
doxy have strong homology to mosquito (Anopheles gam-
biae) transcripts involved in DNA integration (14927.
m00099), nucleic acid binding (15547.m00008), citric acid
cycle (13478.m00071) or transport (15547.m00008, 14979.
m04385, 12526.m00074). Sequence similarities to mos-
quito gene fragments have been reported in the Bm gen-
ome and in V2 gene expression studies [36]; (Li et al.,
unpublished observations) and in proteomic profiles of tet-
racycline treated worms [67] indicating occurrence of
DNA integration of mosquitoes with Brugia nematodes.
In C. elegans, RNAi screening has demonstrated
abnormal phenotypes for about 5000 genes which is
about 25% of all predicted genes [69,70]. It has been
shown that about 30% of predicted genes in Bm with
homologues in C. elegans have RNAi phenotypes in that
species [36,37]. Among the genes represented in the V2
filarial array, approximately 37% with homologues in C.
elegans have RNAi phenotypes [40]. The increased rate
of phenotypes for filarial genes with C. elegans homolo-
gues suggest that many of these genes are necessary for
core nematode pathways that are conserved across the
phylum.
Conclusions
In summary, this study has provided detailed informa-
tion on effects of doxy treatment on gene expression in
wBm and adult female Bm. As expected, treatment gen-
erally reduced wBm gene expression. However, this was
not uniform, and expression of many wBm genes was
not affected by doxy. Doxycycline had a mixed effect on
Bm gene expression. Reduced expression of genes
involved in reproduction, growth and development was
consistent with sterility observed in doxy treated worms.
The up-regulated genes and pathways in treated worms
were less predictable. Up-regulation of energy
production (oxidative phosphorylation, carbohydrate
metabolism), electron transport, antioxidants, proteases
and immunomodulatory genes may represent parasite
adaptations that permit survival (albeit with sterility)
when related functions normally provided by wBm are
disrupted by doxy treatment. For example, the energy
and electron transport findings suggest that increased
mitochondrial activity may help the worms survive the
loss of wBm. It is possible that wBm normally function
as accessory mitochondria providing extra energy in
metabolically active tissues. Additional work will be
needed to test this interesting hypothesis. The challenge
remains to determine which of these changes in gene
expression are critical adaptations and which are sec-
ondary effects or general responses to stress conditions.
It would be interesting to compare doxy effects on gene
expression in filarial worms to those caused by other
antifilarial drugs.
Additional material
Additional file 1: Effect of doxycycline on Brugia malayi female
worm embryogenesis. Embryograms for untreated and doxycycline
(Doxy) treated female worms. Data shown are percentages of early
developing embryos, pretzels and stretched MF (microfilaria) in worm
homogenates. Differences between embryograms from untreated and
treated worms were highly significant (P < 0.001).
Additional file 2: Distribution of Wolbachia and Brugia malayi
elements in V2 filarial array hybridized with cDNA from
doxycycline* treated or control worms.
Additional file 3: Wolbachia elements and their signal strength in
V2 filarial array hybridized to control Brugia malayi worm RNA. This
table describes the baseline expression signals for top 25 Wolbachia
genes and their predicted gene ontology (GO) annotations.
Additional file 4: Wolbachia genes in treated and control Brugia
malayi worms. This list shows Wolbachia elements with signals present
(P) or absent (A) in treated and control worms
Additional file 5: Expression profiles for filarial and Wolbachia
genes using the V2 filarial array after doxycycline treatment.
Expression signals were documented by plotting the photomultiplier
(PMT) signals at high intensities. Panel A (for all elements on the array)
and panel B (Wolbachia elements only) are scatter plots displaying the
mean normalized fluorescence intensity signals for elements in treated
vs. control female worms. Up-regulated and down-regulated genes are
shown in red and blue, respectively. 200 and 546 genes showing ≥ 2
fold change with P ≤ 0.01 were considered to be differentially expressed
in Wolbachia and Brugia malayi after doxy treatment. Tx: treated; C:
control.
Additional file 6: Differentially expressed Wolbachia genes in Brugia
malayi (≥ 2 fold change, P < 0.01) after doxycycline treatment. This
table contains lists of up-regulated (in red) and down-regulated (in blue)
wBm genes with their normalized expression units (ratios and P values),
gene descriptions, Basic Local Alignment Search Tool (BLAST)-NR hits and
their available GO assignments.
Additional file 7: Functional classification by Koyoto Encyclopedia
of Genes and Genomes (KEGG) of differentially expressed
Wolbachia genes in Brugia malayi after doxycycline treatment.
Summary sheet include number of wBm genes that are represented in
the V2-filarial array and their associated pathways. Frequent pathways
mapped to the differentially expressed wBm genes are shown in this
table with their ko numbers. A hypergeometric cumulative distribution
function (cdf) for each KEGG pathway was applied to identify the
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enriched pathways. Statistically significant (P < 0.05) pathways ranked by
gene abundance are shown in red.
Additional file 8: Results of InterPro scans to show protein domains
enriched in the differentially expressed Wolbachia genes in Brugia
malayi after doxycycline treatment. Significantly enriched protein
domains in wBm are shown in red.
Additional file 9: Brugia malayi genes in doxycycline treated and
control worms. This list shows Brugia malayi elements with signals
present (P) or absent (A) in treated and control worms. C. elegans
homologues for RNAi phenotypes for corresponding Bm genes in
treated worms are listed in this table.
Additional file 10: Functional analysis (KEGG and GO) for genes
present in treated but absent in control Brugia malayi female
worms. Statistically significant pathways and GO terms are shown in this
table.
Additional file 11: Summary of differentially expressed Brugia
malayi genes after doxycycline treatment. This table contains lists of
up-regulated (in red) and down-regulated (in blue) genes, normalized
expression units (ratios and P values) and their corresponding
annotations, Caenorhabditis elegans Blast Hits, matching C. elegans RNAi
phenotypes, GO assignments, mapped KEGG pathways and their KO hits.
InterPro scan results for matched protein domains are included for many
differentially expressed genes.
Additional file 12: Functional classification by KEGG of differentially
expressed Brugia malayi genes after doxycycline treatment. This
table shows summary of KEGG mappings for all Bm genes represented in
V2-filarial array and for differentially expressed Bm genes. Pathways
ranked by gene abundance are shown for all regulated genes.
Additional file 13: Results of InterPro scan analysis for protein
domains enriched in the differentially expressed Brugia malayi
genes after doxycycline treatment. Significantly (P ≤ 0.05) enriched
protein domains mapped to the Bm genes are shown in red.
Additional file 14: Results of qRT-PCR assays for Wolbachia and
Brugia malayi genes in female worms after doxycycline treatment
relative to control worms. Panel A shows expression changes for wBm
16S rRNA, ftsZ and wsp transcripts and Bm-shp1, Bm-FABP1 and Bm-actin
transcripts. Panel B shows changes in Wolbachia genes in the heme
synthesis pathway. Expression profiles of 16S rRNA, ftsZ and wsp and
Bm-shp1, FABP and heme genes relative to controls were significantly
down-regulated (P < 0.05).
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Bm: Brugia malayi; wBm: Wolbachia; Doxy: doxycycline; qRT-PCR: quantitative
reverse transcription polymerase chain reaction; KEGG: Koyoto Encyclopedia
of Genes and Genomes; KO: KEGG Ontology; GO: Gene Ontology; RNAi: RNA
interference; MF: microfilaria
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